InvestorsHub Logo
Followers 50
Posts 9053
Boards Moderated 1
Alias Born 01/13/2007

Re: HANUMAN post# 2521

Monday, 10/11/2021 4:10:16 PM

Monday, October 11, 2021 4:10:16 PM

Post# of 3576
No. Unless someone has any info to the contrary which I have not seen, nor would make sense IMO.

Cassava is where they need to be. They are running their first placebo controlled trial. They are making sure 100 mg is the proper dose and they are making it big enough for the FDA to grant approval if efficacy is shown. As with all drug stocks, you get to a point where you have to have patience before you see results. Stock could go down. Stock could go up but regardless its a 2 year wait now. Even IF, and I give this almost no chance, they have an interim readout you are still talking 18 months. Company has given no indication of such either and what some don't understand is it hurts your probability model by peaking. Patience.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News